🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multicenter, open-label, randomized controlled trial that e...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital
Start Date
2025-09-25
Trial ID
NCT07165418
Treatments Being Tested
This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerabilit...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2015-09
Trial ID
NCT02577458
Treatments Being Tested
This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinet...
Status
Suspended
Location
Peking Union Medical College Hospital
Start Date
2019-12-18
Trial ID
NCT04222842
Treatments Being Tested
This is a two-agent, open-label, non-randomized, Phase 1/2 dose escalation ...
Status
Completed
Location
Stanford Cancer Institute
Start Date
2018-07-10
Trial ID
NCT03583086
This study evaluates the efficacy and safety of Vorolanib as monotherapy fo...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2024-12-01
Trial ID
NCT06728852
Treatments Being Tested
This study was a one-arm, single-center, phase II clinical study. Patients ...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2018-07-31
Trial ID
NCT03602547
Treatments Being Tested
Evaluate the efficacy and safety of vorolanib combined with cadonilimab in ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-31
Trial ID
NCT06577961
Treatments Being Tested
This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinet...
Status
Unknown
Location
Shanghai East Hospital
Start Date
2019-02-26
Trial ID
NCT03792958
Treatments Being Tested
A prospective, randomized, single-masked study evaluating the ocular effica...
Status
Completed
Location
EyePoint Investigative Site
Start Date
2024-01-15
Trial ID
NCT06099184
Treatments Being Tested